Eli Lilly’s GIP/GLP-1 dual receptor agonist Mounjaro (tirzepatide) has demonstrated cardiovascular protection in a late-stage ...

The new initiative, FDA PreCheck, was developed in response to President Donald Trump’s executive order to accelerate the ...

The most widely used measure of health-related self-efficacy is the Patient Activation Measure (PAM). It is a ...

This Phase III global clinical trial for patients with either stage IIIB or IV unresectable melanoma involved 118 research ...

The Medscape Global team is bringing their leading cardiology education and proven impact to the European Society of ...

MSD – known as Merck & Co in the US and Canada – has announced that its anti-PD-1 therapy Keytruda (pembrolizumab) has been ...

Novo Nordisk has announced the appointment of Maziar Mike Doustdar as its new president and chief executive officer (CEO).

In response, medical communications planning has become increasingly integrated, allowing customised user experiences across ...

Medical and scientific innovation are in a fast lane closely pursued by digital advances but their dynamism can mute a vital ...

It is hoped the new formulation will offer patients greater freedom and flexibility compared to the liquid version ...

Apogee Therapeutics has shared positive 16-week results from a mid-stage study of its investigational anti-IL-13 antibody in ...

Patient engagement is one of the most reliable ways to drive long-term health outcomes and a critical benchmark for ...